Asymmetry in the PPARγ/RXRα crystal structure reveals the molecular basis of heterodimerization among nuclear receptors

被引：517

作者：

Gampe, RT ^{[1
]}

Montana, VG ^{[1
]}

Lambert, MH ^{[1
]}

Miller, AB ^{[1
]}

Bledsoe, RK ^{[1
]}

Milburn, MV ^{[1
]}

Kliewer, SA ^{[1
]}

Willson, TM ^{[1
]}

Xu, HE ^{[1
]}

机构：

[1] Glaxo Wellcome Res & Dev, Res Triangle Pk, NC 27709 USA

来源：

MOLECULAR CELL | 2000年 / 5卷 / 03期

关键词：

D O I：

10.1016/S1097-2765(00)80448-7

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The nuclear receptor PPAR gamma/RXR alpha heterodimer regulates glucose and lipid homeostasis and is the target for the antidiabetic drugs G1262570 and the thiazolidinediones (TZDs). We report the crystal structures of the PPAR gamma and RXR alpha LBDs complexed to the RXR ligand 9-cis-retinoic acid (9cRA), the PPAR gamma agonist rosiglitazone or G1262570, and coactivator peptides. The PPAR gamma/RXR alpha heterodimer is asymmetric, with each LED deviated similar to 10 degrees from the C2 symmetry, allowing the PPAR gamma AF-2 helix to interact with helices 7 and 10 of RXR alpha. The heterodimer interface is composed of conserved motifs in PPAR gamma and RXR alpha that form a coiled coil along helix 10 with additional charge interactions from helices 7 and 9. The structures provide a molecular understanding of the ability of RXR to heterodimerize with many nuclear receptors and of the permissive activation of the PPAR gamma/RXR alpha heterodimer by 9cRA.

引用

页码：545 / 555

页数：11

共 39 条

[1]

[Anonymous], ACTA CRYSTALLOGR D

[2]

Auwerx J, 1999, CELL, V97, P161

[3] Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains [J].

Bourguet, W ;

Vivat, V ;

Wurtz, JM ;

Chambon, P ;

Gronemeyer, H ;

Moras, D .

MOLECULAR CELL, 2000, 5 (02) :289-298

[4] CRYSTAL-STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA [J].

BOURGUET, W ;

RUFF, M ;

CHAMBON, P ;

GRONEMEYER, H ;

MORAS, D .

NATURE, 1995, 375 (6530) :377-382

[5] A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-γ reverses the diabetic phenotype of the Zucker diabetic fatty rat [J].

Brown, KK ;

Henke, BR ;

Blanchard, SG ;

Cobb, JE ;

Mook, R ;

Kaldor, I ;

Kliewer, SA ;

Lehmann, JM ;

Lenhard, JM ;

Harrington, WW ;

Novak, PJ ;

Faison, W ;

Binz, JG ;

Hashim, MA ;

Oliver, WO ;

Brown, HR ;

Parks, DJ ;

Plunket, KD ;

Tong, WQ ;

Menius, JA ;

Adkison, K ;

Noble, SA ;

Willson, TM .

DIABETES, 1999, 48 (07) :1415-1424

[6] Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].

Brunger, AT ;

Adams, PD ;

Clore, GM ;

DeLano, WL ;

Gros, P ;

Grosse-Kunstleve, RW ;

Jiang, JS ;

Kuszewski, J ;

Nilges, M ;

Pannu, NS ;

Read, RJ ;

Rice, LM ;

Simonson, T ;

Warren, GL .

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921

[7] Molecular basis of agonism and antagonism in the oestrogen receptor [J].

Brzozowski, AM ;

Pike, ACW ;

Dauter, Z ;

Hubbard, RE ;

Bonn, T ;

Engstrom, O ;

Ohman, L ;

Greene, GL ;

Gustafsson, JA ;

Carlquist, M .

NATURE, 1997, 389 (6652) :753-758

[8] SOLVENT-ACCESSIBLE SURFACES OF PROTEINS AND NUCLEIC-ACIDS [J].

CONNOLLY, ML .

SCIENCE, 1983, 221 (4612) :709-713

[9] Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta [J].

Forman, BM ;

Chen, J ;

Evans, RM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) :4312-4317

[10] Increasing the complexity of coactivation in nuclear receptor signaling [J].

Freedman, LP .

CELL, 1999, 97 (01) :5-8

← 1 2 3 4 →